Activation Transcription Factor 1 Involvement in the Regulation of Murine H-2D Expression

Nobuhisa Ishiguro, G. Dalon Brown, Daniel Meruelo

Journal of Biological Chemistry · 1997 · 13 citations · 68 references

DOIFull text

Open access

Concepts

Abstract

Resistance to radiation leukemia virus-induced leukemia is correlated with an increase in H-2D expression on the thymocyte surface. Recently, it has been shown that elevated H-2Dd expression on the infected thymocyte is a result of elevated mRNA transcription and that the transcriptional increase is correlated with elevated levels of a DNA binding activity, H-2 binding factor 1 (H-2 BF1), which recognizes the 5′-flanking sequences (5′-TGACGCG-3′) of the H-2D d gene. This target for transcription factor binding has been found to be identical in the 5′-regulatory region of 12 rodent class I genes, nine of which have been shown to be functional genes. Furthermore, thiscis-element is found 5′ of 20 primate class I genes (15 human genes), seven of which are known to be functional. Here, we demonstrate that activation transcription factor 1 (ATF-1) is one component of H-2 BF1. In addition, the levels of ATF-1mRNA in uninfected and radiation leukemia virus-infected thymocytes parallel those of H-2D d mRNA, and therefore, it is suggested that ATF-1 up-regulates the transcription of theH-2D d gene after radiation leukemia virus infection of thymocytes. Transfection experiments also demonstrate that ATF-1 activates a reporter plasmid that contains the H-2 BF1 motif, but not a reporter lacking this motif. This is the first demonstration of the interaction of ATF-1 with 5′-regulatory sequences of major histocompatibility complex class I genes. Resistance to radiation leukemia virus-induced leukemia is correlated with an increase in H-2D expression on the thymocyte surface. Recently, it has been shown that elevated H-2Dd expression on the infected thymocyte is a result of elevated mRNA transcription and that the transcriptional increase is correlated with elevated levels of a DNA binding activity, H-2 binding factor 1 (H-2 BF1), which recognizes the 5′-flanking sequences (5′-TGACGCG-3′) of the H-2D d gene. This target for transcription factor binding has been found to be identical in the 5′-regulatory region of 12 rodent class I genes, nine of which have been shown to be functional genes. Furthermore, thiscis-element is found 5′ of 20 primate class I genes (15 human genes), seven of which are known to be functional. Here, we demonstrate that activation transcription factor 1 (ATF-1) is one component of H-2 BF1. In addition, the levels of ATF-1mRNA in uninfected and radiation leukemia virus-infected thymocytes parallel those of H-2D d mRNA, and therefore, it is suggested that ATF-1 up-regulates the transcription of theH-2D d gene after radiation leukemia virus infection of thymocytes. Transfection experiments also demonstrate that ATF-1 activates a reporter plasmid that contains the H-2 BF1 motif, but not a reporter lacking this motif. This is the first demonstration of the interaction of ATF-1 with 5′-regulatory sequences of major histocompatibility complex class I genes. The MHC 1The abbreviations used are: MHC, major histocompatibility complex; RadLV, radiation leukemia virus; H-2 BF1, H-2 binding factor 1; CRE, cyclic AMP-responsive element; ATF-1, activation transcription factor 1; kb, kilobase pair(s); bp, base pair(s); CREB, CRE-binding protein. 1The abbreviations used are: MHC, major histocompatibility complex; RadLV, radiation leukemia virus; H-2 BF1, H-2 binding factor 1; CRE, cyclic AMP-responsive element; ATF-1, activation transcription factor 1; kb, kilobase pair(s); bp, base pair(s); CREB, CRE-binding protein. encodes highly polymorphic cell-surface antigens that play an important role in recognition and elimination of virus-infected or neoplastic cells by the immune system (1Klein J. Figueroa F. Nagy Z.A. Annu. Rev. Immunol. 1983; 1: 119-142Crossref PubMed Scopus (99) Google Scholar, 2Hood L. Steinmetz M. Malissen B. Annu. Rev. Immunol. 1983; 1: 529-568Crossref PubMed Scopus (267) Google Scholar). Murine H-2 class I gene expression has been shown to be significantly altered in thymic cells after both radiation leukemia virus (RadLV) infection and RadLV-induced transformation (3Meruelo D. Nimelstein S.H. Jones P.P. Lieberman M. McDevitt H.O. J. Exp. Med. 1978; 147: 470-487Crossref PubMed Scopus (62) Google Scholar). Early studies using H-2 congenic mouse strains demonstrated that the H-2D d locus of the MHC is sufficient to result in resistance to RadLV-induced thymoma development (4Meruelo D. Lieberman M. Ginzten N. Deak B. McDevitt H.O. J. Exp. Med. 1977; 146: 1079-1087Crossref PubMed Scopus (51) Google Scholar). Following infection of resistant mouse strains, there is a rapid increase in the level of Dd antigen on the surface of infected thymocytes. The immune system of resistant strains recognizes the infected cells, and a cell-mediated immune response is detectable in vitro; no such immune response is seen in susceptible hosts (5Meruelo D. J. Exp. Med. 1979; 149: 898-909Crossref PubMed Scopus (39) Google Scholar). Soon thereafter, the virus-infected cells are eliminated from the resistant mice, and tumors arise in only a very small percentage of these animals (5Meruelo D. J. Exp. Med. 1979; 149: 898-909Crossref PubMed Scopus (39) Google Scholar). In the susceptible mouse strains (mice carrying theH-2D gene of a haplotype other than D d), the levels of H-2 expression are variable, no cell-mediated immune response is generated, and a high percentage of infected mice go on to develop thymomas. These observations clearly indicate the importance of immunosurveillance in determining the phenotypic response (resistanceversus susceptible) following RadLV infection and potential tumorigenesis.More recently, we have examined the stimulation of H-2Ddexpression at the molecular level. It was shown that infection by RadLV results in the increased transcription of H-2 gene(s) and a concomitant increase in H-2Dd antigen on the surface of the thymocytes (6Brown G.D. Nobunaga T. Morris D.R. Meruelo D. Res. Immunol. 1991; 142: 431-440Crossref PubMed Scopus (5) Google Scholar). Also detectable in nuclear extracts prepared from infected thymocytes is an increased DNA binding activity that specifically recognizes the sequence 5′-TGACGCG-3′ in the 5′-flanking region of the H-2D d gene. Thistrans-acting factor has been termed H-2 binding factor 1 (H-2 BF1). The importance of this CRE-like cis-factor in class I regulation was first noted by Israel et al. (7Israel A. Le Bail O. Hatat D. Piette J. Kieran M. Logeat F. Wallach D. Fellous M. Kourilsky P. EMBO J. 1989; 8: 3793-3800Crossref PubMed Scopus (201) Google Scholar) in 1989 and subsequently by Dey et al. (8Dey A. Thornton A.M. Lonergan M. Weissman S.M. Chamberlain J.W. Ozato K. Mol. Cell. Biol. 1992; 12: 3590-3599Crossref PubMed Scopus (65) Google Scholar), Saji et al. (9Saji M. Moriarty J. Ban T. Kohn L.D. Singer D.S. Proc. Natl. Acad. Sci. U. S. A. 1992; 89: 1944-1948Crossref PubMed Scopus (51) Google Scholar), and Nobunaga et al. (10Nobunaga T. Brown G.D. Morris D.R. Meruelo D. J. Immunol. 1992; 149: 871-879PubMed Google Scholar) in 1992. Although, in these studies, the biological function of this cis-element in class I regulation was suggested, the trans-factor(s) that bound to this element were not identified. We have previously shown that proteins of 27 and 65 kDa bind to thiscis-sequence as determined by UV photocross-linking studies (10Nobunaga T. Brown G.D. Morris D.R. Meruelo D. J. Immunol. 1992; 149: 871-879PubMed Google Scholar).After an exhaustive search of GenBank™ sequences, we have shown that this target binding sequence is present in the 5′-regulatory region of many class I genes. Notable among the findings is that thiscis-element is identical in 17 out of 22 class I genes that have been shown to be functional, i.e. not pseudogenes, by transfection analysis. The extraordinary conservation of this sequence across evolutionary lines emphasizes its potential importance in the regulation of expression of the major histocompatibility antigens.In the experiments described here, we have screened a plasmid cDNA expression library using the yeast one-hybrid system (11Wang M.M. Reed R.R. Nature. 1993; 364: 121-126Crossref PubMed Scopus (368) Google Scholar). Numerous cDNA clones have been isolated, and one group of these cDNA clones is shown to encode activation transcription factor 1 (ATF-1). Using gel supershift assays, ATF-1 is demonstrated to be one component of the in vivo H-2 BF1 complex. Several facts support this evidence. Both human and mouse ATF-1 are known to bind to the CRE binding motif (12Hai T. F. 1989; PubMed Scopus Google Scholar, M. J. Immunol. 1992; Google Scholar), which is to the H-2 BF1 binding Murine ATF-1 has a molecular of to the in UV studies of H-2 BF1 (10Nobunaga T. Brown G.D. Morris D.R. Meruelo D. J. Immunol. 1992; 149: 871-879PubMed Google Scholar). The expression level of mRNA ATF-1 that of H-2 mRNA in both and Transfection experiments also demonstrate that ATF-1 activates a reporter plasmid that contains the H-2 BF1 motif. These observations that ATF-1 is both in the regulation of H-2 expression and in the stimulation of transcription from the H-2D d gene after RadLV infection of mouse experiments in the RadLV system the importance of immunosurveillance in and the that altered MHC expression has on the of the immune response of the to virus-infected in other leukemia leukemia and and DNA and also demonstrated in class I gene expression from G.D. Meruelo D. P. of the Scholar). In of class I gene expression has been correlated with The that from of these is that infection to transcription and MHC transformation to The result of these is highly for the of the immune system to or to to It has been that antigens are to immune cells in the of histocompatibility in the have to the recognition that the expression of MHC is as important to the of the immune system as is the of the MHC is to the by which expression of MHC first demonstrated that in cells, increased cell-surface expression of H-2Dd antigen is a result of elevated levels of transcription (10Nobunaga T. Brown G.D. Morris D.R. Meruelo D. J. Immunol. 1992; 149: 871-879PubMed Google Scholar). element was DNA the complex that and with this sequence was termed H-2 BF1 and was shown to be of at one of which a molecular of kDa (6Brown G.D. Nobunaga T. Morris D.R. Meruelo D. Res. Immunol. 1991; 142: 431-440Crossref PubMed Scopus (5) Google Scholar, T. Brown G.D. Morris D.R. Meruelo D. J. Immunol. 1992; 149: 871-879PubMed Google Scholar). The cis-element is of in that it has been found to be in the of nine out of nine known functional genes the sequence is identical in the of primate MHC genes that have been shown to be the experiments described here, we have used the yeast one-hybrid system to ATF-1 as one component of H-2 BF1. H-2 BF1 is the transcriptional complex G.D. N. Meruelo D. Immunol. Scholar) that recognizes sequences (5′-TGACGCG-3′) 5′ of the H-2D d gene. The molecular of ATF-1 that of one component of H-2 BF1 as from UV photocross-linking studies (10Nobunaga T. Brown G.D. Morris D.R. Meruelo D. J. Immunol. 1992; 149: 871-879PubMed Google Scholar). ATF-1 was by cDNA with DNA the CRE (12Hai T. F. 1989; PubMed Scopus Google Scholar, M. J. Immunol. 1992; Google Scholar). The CRE binding motif is known to be for the transcriptional activity of many Mol. Cell. Biol. 8: PubMed Scopus Google Scholar, Mol. Cell. Biol. 8: PubMed Scopus Google Scholar), and ATF-1 has been shown to be in the expression of genes, and M.M. S.H. J. Immunol. Google Scholar, N. D. S.H. N. J. Immunol. Google Scholar, M. K. Res. PubMed Scopus Google Scholar, T. M. Kourilsky P. PubMed Scopus Google Scholar). that ATF-1 bind both to the CRE binding motif and to the H-2 BF1 motif. The that the of the H-2 complex in gel is of the that ATF-1 is one component of the H-2 BF1 complex. that the levels of H-2 mRNA in of thymocyte very parallel those of ATF-1 Transfection experiments also demonstrate that ATF-1 activates the reporter plasmid that contains the H-2 BF1 motif, but not the plasmid the H-2 BF1 motif. it is also suggested that ATF-1 up-regulates the transcription of theH-2D d gene after RadLV infection of thymocytes. This is the first ATF-1 in the transcriptional regulation of class I MHC we demonstrated that the H-2 BF1 complex was of at proteins with molecular of 27 and 65 kDa (6Brown G.D. Nobunaga T. Morris D.R. Meruelo D. Res. Immunol. 1991; 142: 431-440Crossref PubMed Scopus (5) Google Scholar, T. Brown G.D. Morris D.R. Meruelo D. J. Immunol. 1992; 149: 871-879PubMed Google Scholar). the for clones the H-2 BF1 binding motif, many clones were that not to that these are the of and in the in of these clones with ATF-1 in It has been shown that with other transcription such as and B. P. P. EMBO J. 1993; 12: PubMed Scopus Google Scholar), the virus B. Mol. Cell. Biol. PubMed Google Scholar), and B. Mol. Cell. Biol. 1993; PubMed Google Scholar). to demonstrate the ATF-1 and in vivo have not been the ATF-1 with in vivo is UV photocross-linking it was noted that of the was very and of the of nuclear extracts and was from to In nuclear a of kDa was also in to the not we have found that the H-2 BF1 complex is of at the ATF-1 and Murine has a molecular of kDa S. M. EMBO J. 1992; PubMed Scopus Google Scholar), and therefore, the in UV photocross-linking is The MHC 1The abbreviations used are: MHC, major histocompatibility complex; RadLV, radiation leukemia virus; H-2 BF1, H-2 binding factor 1; CRE, cyclic AMP-responsive element; ATF-1, activation transcription factor 1; kb, kilobase pair(s); bp, base pair(s); CREB, CRE-binding protein. 1The abbreviations used are: MHC, major histocompatibility complex; RadLV, radiation leukemia virus; H-2 BF1, H-2 binding factor 1; CRE, cyclic AMP-responsive element; ATF-1, activation transcription factor 1; kb, kilobase pair(s); bp, base pair(s); CREB, CRE-binding protein. encodes highly polymorphic cell-surface antigens that play an important role in recognition and elimination of virus-infected or neoplastic cells by the immune system (1Klein J. Figueroa F. Nagy Z.A. Annu. Rev. Immunol. 1983; 1: 119-142Crossref PubMed Scopus (99) Google Scholar, 2Hood L. Steinmetz M. Malissen B. Annu. Rev. Immunol. 1983; 1: 529-568Crossref PubMed Scopus (267) Google Scholar). Murine H-2 class I gene expression has been shown to be significantly altered in thymic cells after both radiation leukemia virus (RadLV) infection and RadLV-induced transformation (3Meruelo D. Nimelstein S.H. Jones P.P. Lieberman M. McDevitt H.O. J. Exp. Med. 1978; 147: 470-487Crossref PubMed Scopus (62) Google Scholar). Early studies using H-2 congenic mouse strains demonstrated that the H-2D d locus of the MHC is sufficient to result in resistance to RadLV-induced thymoma development (4Meruelo D. Lieberman M. Ginzten N. Deak B. McDevitt H.O. J. Exp. Med. 1977; 146: 1079-1087Crossref PubMed Scopus (51) Google Scholar). Following infection of resistant mouse strains, there is a rapid increase in the level of Dd antigen on the surface of infected thymocytes. The immune system of resistant strains recognizes the infected cells, and a cell-mediated immune response is detectable in vitro; no such immune response is seen in susceptible hosts (5Meruelo D. J. Exp. Med. 1979; 149: 898-909Crossref PubMed Scopus (39) Google Scholar). Soon thereafter, the virus-infected cells are eliminated from the resistant mice, and tumors arise in only a very small percentage of these animals (5Meruelo D. J. Exp. Med. 1979; 149: 898-909Crossref PubMed Scopus (39) Google Scholar). In the susceptible mouse strains (mice carrying theH-2D gene of a haplotype other than D d), the levels of H-2 expression are variable, no cell-mediated immune response is generated, and a high percentage of infected mice go on to develop thymomas. These observations clearly indicate the importance of immunosurveillance in determining the phenotypic response (resistanceversus susceptible) following RadLV infection and potential recently, we have examined the stimulation of H-2Ddexpression at the molecular level. It was shown that infection by RadLV results in the increased transcription of H-2 gene(s) and a concomitant increase in H-2Dd antigen on the surface of the thymocytes (6Brown G.D. Nobunaga T. Morris D.R. Meruelo D. Res. Immunol. 1991; 142: 431-440Crossref PubMed Scopus (5) Google Scholar). Also detectable in nuclear extracts prepared from infected thymocytes is an increased DNA binding activity that specifically recognizes the sequence 5′-TGACGCG-3′ in the 5′-flanking region of the H-2D d gene. Thistrans-acting factor has been termed H-2 binding factor 1 (H-2 BF1). The importance of this CRE-like cis-factor in class I regulation was first noted by Israel et al. (7Israel A. Le Bail O. Hatat D. Piette J. Kieran M. Logeat F. Wallach D. Fellous M. Kourilsky P. EMBO J. 1989; 8: 3793-3800Crossref PubMed Scopus (201) Google Scholar) in 1989 and subsequently by Dey et al. (8Dey A. Thornton A.M. Lonergan M. Weissman S.M. Chamberlain J.W. Ozato K. Mol. Cell. Biol. 1992; 12: 3590-3599Crossref PubMed Scopus (65) Google Scholar), Saji et al. (9Saji M. Moriarty J. Ban T. Kohn L.D. Singer D.S. Proc. Natl. Acad. Sci. U. S. A. 1992; 89: 1944-1948Crossref PubMed Scopus (51) Google Scholar), and Nobunaga et al. (10Nobunaga T. Brown G.D. Morris D.R. Meruelo D. J. Immunol. 1992; 149: 871-879PubMed Google Scholar) in 1992. Although, in these studies, the biological function of this cis-element in class I regulation was suggested, the trans-factor(s) that bound to this element were not identified. We have previously shown that proteins of 27 and 65 kDa bind to thiscis-sequence as determined by UV photocross-linking studies (10Nobunaga T. Brown G.D. Morris D.R. Meruelo D. J. Immunol. 1992; 149: 871-879PubMed Google Scholar). an exhaustive search of GenBank™ sequences, we have shown that this target binding sequence is present in the 5′-regulatory region of many class I genes. Notable among the findings is that thiscis-element is identical in 17 out of 22 class I genes that have been shown to be functional, i.e. not pseudogenes, by transfection analysis. The extraordinary conservation of this sequence across evolutionary lines emphasizes its potential importance in the regulation of expression of the major histocompatibility In the experiments described here, we have screened a plasmid cDNA expression library using the yeast one-hybrid system (11Wang M.M. Reed R.R. Nature. 1993; 364: 121-126Crossref PubMed Scopus (368) Google Scholar). Numerous cDNA clones have been isolated, and one group of these cDNA clones is shown to encode activation transcription factor 1 (ATF-1). Using gel supershift assays, ATF-1 is demonstrated to be one component of the in vivo H-2 BF1 complex. Several facts support this evidence. Both human and mouse ATF-1 are known to bind to the CRE binding motif (12Hai T. F. 1989; PubMed Scopus Google Scholar, M. J. Immunol. 1992; Google Scholar), which is to the H-2 BF1 binding Murine ATF-1 has a molecular of to the in UV studies of H-2 BF1 (10Nobunaga T. Brown G.D. Morris D.R. Meruelo D. J. Immunol. 1992; 149: 871-879PubMed Google Scholar). The expression level of mRNA ATF-1 that of H-2 mRNA in both and Transfection experiments also demonstrate that ATF-1 activates a reporter plasmid that contains the H-2 BF1 motif. These observations that ATF-1 is both in the regulation of H-2 expression and in the stimulation of transcription from the H-2D d gene after RadLV infection of mouse thymocytes. experiments in the RadLV system the importance of immunosurveillance in and the that altered MHC expression has on the of the immune response of the to virus-infected in other leukemia leukemia and and DNA and also demonstrated in class I gene expression from G.D. Meruelo D. P. of the Scholar). In of class I gene expression has been correlated with The that from of these is that infection to transcription and MHC transformation to The result of these is highly for the of the immune system to or to to It has been that antigens are to immune cells in the of histocompatibility in the have to the recognition that the expression of MHC is as important to the of the immune system as is the of the MHC is to the by which expression of MHC first demonstrated that in cells, increased cell-surface expression of H-2Dd antigen is a result of elevated levels of transcription (10Nobunaga T. Brown G.D. Morris D.R. Meruelo D. J. Immunol. 1992; 149: 871-879PubMed Google Scholar). element was DNA the complex that and with this sequence was termed H-2 BF1 and was shown to be of at one of which a molecular of kDa (6Brown G.D. Nobunaga T. Morris D.R. Meruelo D. Res. Immunol. 1991; 142: 431-440Crossref PubMed Scopus (5) Google Scholar, T. Brown G.D. Morris D.R. Meruelo D. J. Immunol. 1992; 149: 871-879PubMed Google Scholar). The cis-element is of in that it has been found to be in the of nine out of nine known functional genes the sequence is identical in the of primate MHC genes that have been shown to be the experiments described here, we have used the yeast one-hybrid system to ATF-1 as one component of H-2 BF1. H-2 BF1 is the transcriptional complex G.D. N. Meruelo D. Immunol. Scholar) that recognizes sequences (5′-TGACGCG-3′) 5′ of the H-2D d gene. The molecular of ATF-1 that of one component of H-2 BF1 as from UV photocross-linking studies (10Nobunaga T. Brown G.D. Morris D.R. Meruelo D. J. Immunol. 1992; 149: 871-879PubMed Google Scholar). ATF-1 was by cDNA with DNA the CRE (12Hai T. F. 1989; PubMed Scopus Google Scholar, M. J. Immunol. 1992; Google Scholar). The CRE binding motif is known to be for the transcriptional activity of many Mol. Cell. Biol. 8: PubMed Scopus Google Scholar, Mol. Cell. Biol. 8: PubMed Scopus Google Scholar), and ATF-1 has been shown to be in the expression of genes, and M.M. S.H. J. Immunol. Google Scholar, N. D. S.H. N. J. Immunol. Google Scholar, M. K. Res. PubMed Scopus Google Scholar, T. M. Kourilsky P. PubMed Scopus Google Scholar). that ATF-1 bind both to the CRE binding motif and to the H-2 BF1 motif. The that the of the H-2 complex in gel is of the that ATF-1 is one component of the H-2 BF1 complex. that the levels of H-2 mRNA in of thymocyte very parallel those of ATF-1 Transfection experiments also demonstrate that ATF-1 activates the reporter plasmid that contains the H-2 BF1 motif, but not the plasmid the H-2 BF1 motif. it is also suggested that ATF-1 up-regulates the transcription of theH-2D d gene after RadLV infection of thymocytes. This is the first ATF-1 in the transcriptional regulation of class I MHC we demonstrated that the H-2 BF1 complex was of at proteins with molecular of 27 and 65 kDa (6Brown G.D. Nobunaga T. Morris D.R. Meruelo D. Res. Immunol. 1991; 142: 431-440Crossref PubMed Scopus (5) Google Scholar, T. Brown G.D. Morris D.R. Meruelo D. J. Immunol. 1992; 149: 871-879PubMed Google Scholar). the for clones the H-2 BF1 binding motif, many clones were that not to that these are the of and in the in of these clones with ATF-1 in It has been shown that with other transcription such as and B. P. P. EMBO J. 1993; 12: PubMed Scopus Google Scholar), the virus B. Mol. Cell. Biol. PubMed Google Scholar), and B. Mol. Cell. Biol. 1993; PubMed Google Scholar). to demonstrate the ATF-1 and in vivo have not been the ATF-1 with in vivo is UV photocross-linking it was noted that of the was very and of the of nuclear extracts and was from to In nuclear a of kDa was also in to the not we have found that the H-2 BF1 complex is of at the ATF-1 and Murine has a molecular of kDa S. M. EMBO J. 1992; PubMed Scopus Google Scholar), and therefore, the in UV photocross-linking is Early experiments in the RadLV system the importance of immunosurveillance in and the that altered MHC expression has on the of the immune response of the to virus-infected in other leukemia leukemia and and DNA and also demonstrated in class I gene expression from G.D. Meruelo D. P. of the Scholar). In of class I gene expression has been correlated with The that from of these is that infection to transcription and MHC transformation to The result of these is highly for the of the immune system to or to to It has been that antigens are to immune cells in the of histocompatibility in the have to the recognition that the expression of MHC is as important to the of the immune system as is the of the MHC is to the by which expression of MHC genes. first demonstrated that in cells, increased cell-surface expression of H-2Dd antigen is a result of elevated levels of transcription (10Nobunaga T. Brown G.D. Morris D.R. Meruelo D. J. Immunol. 1992; 149: 871-879PubMed Google Scholar). element was DNA the complex that and with this sequence was termed H-2 BF1 and was shown to be of at one of which a molecular of kDa (6Brown G.D. Nobunaga T. Morris D.R. Meruelo D. Res. Immunol. 1991; 142: 431-440Crossref PubMed Scopus (5) Google Scholar, T. Brown G.D. Morris D.R. Meruelo D. J. Immunol. 1992; 149: 871-879PubMed Google Scholar). The cis-element is of in that it has been found to be in the of nine out of nine known functional genes the sequence is identical in the of primate MHC genes that have been shown to be functional. In the experiments described here, we have used the yeast one-hybrid system to ATF-1 as one component of H-2 BF1. H-2 BF1 is the transcriptional complex G.D. N. Meruelo D. Immunol. Scholar) that recognizes sequences (5′-TGACGCG-3′) 5′ of the H-2D d gene. The molecular of ATF-1 that of one component of H-2 BF1 as from UV photocross-linking studies (10Nobunaga T. Brown G.D. Morris D.R. Meruelo D. J. Immunol. 1992; 149: 871-879PubMed Google Scholar). ATF-1 was by cDNA with DNA the CRE (12Hai T. F. 1989; PubMed Scopus Google Scholar, M. J. Immunol. 1992; Google Scholar). The CRE binding motif is known to be for the transcriptional activity of many Mol. Cell. Biol. 8: PubMed Scopus Google Scholar, Mol. Cell. Biol. 8: PubMed Scopus Google Scholar), and ATF-1 has been shown to be in the expression of genes, and M.M. S.H. J. Immunol. Google Scholar, N. D. S.H. N. J. Immunol. Google Scholar, M. K. Res. PubMed Scopus Google Scholar, T. M. Kourilsky P. PubMed Scopus Google Scholar). that ATF-1 bind both to the CRE binding motif and to the H-2 BF1 motif. The that the of the H-2 complex in gel is of the that ATF-1 is one component of the H-2 BF1 complex. that the levels of H-2 mRNA in of thymocyte very parallel those of ATF-1 Transfection experiments also demonstrate that ATF-1 activates the reporter plasmid that contains the H-2 BF1 motif, but not the plasmid the H-2 BF1 motif. it is also suggested that ATF-1 up-regulates the transcription of theH-2D d gene after RadLV infection of thymocytes. This is the first ATF-1 in the transcriptional regulation of class I MHC genes. we demonstrated that the H-2 BF1 complex was of at proteins with molecular of 27 and 65 kDa (6Brown G.D. Nobunaga T. Morris D.R. Meruelo D. Res. Immunol. 1991; 142: 431-440Crossref PubMed Scopus (5) Google Scholar, T. Brown G.D. Morris D.R. Meruelo D. J. Immunol. 1992; 149: 871-879PubMed Google Scholar). the for clones the H-2 BF1 binding motif, many clones were that not to that these are the of and in the in of these clones with ATF-1 in It has been shown that with other transcription such as and B. P. P. EMBO J. 1993; 12: PubMed Scopus Google Scholar), the virus B. Mol. Cell. Biol. PubMed Google Scholar), and B. Mol. Cell. Biol. 1993; PubMed Google Scholar). to demonstrate the ATF-1 and in vivo have not been the ATF-1 with in vivo is UV photocross-linking it was noted that of the was very and of the of nuclear extracts and was from to In nuclear a of kDa was also in to the not we have found that the H-2 BF1 complex is of at the ATF-1 and Murine has a molecular of kDa S. M. EMBO J. 1992; PubMed Scopus Google Scholar), and therefore, the in UV photocross-linking is We Reed for the yeast and plasmid and for in the of J. for the for of the mice, for the and A. for the and for the of this

References

68